Journal of Biological Chemistry · 2000 · 70 citations · 43 references
Life SciencesBiochemistryMolecular BiologyCell SignalingProtein-protein InteractionsSignal TransductionEnzyme InhibitionPeptide AnalysisPeptide ChemistryStable Protein ComplexesG Protein-coupled SignalingPeptide StabilizationPhosphorylation EffectsRhodopsin FunctionRhodopsin Phototransduction
Arrestin blocks the interaction of rhodopsin with the G protein transducin (Gt). To characterize the sites of arrestin that interact with rhodopsin, we have utilized a spectrophotometric peptide competition assay. It is based on the stabilization of the active intermediates metarhodopsin II (MII) and phosphorylated MII by Gt and arrestin, respectively (extra MII monitor). The protocol involves native disc membranes and three sets of peptides 10–30 amino acids in length spanning the arrestin sequence. In the absence of arrestin, not one of the peptides by itself had an effect on the amount of MII formed. However, inhibition of arrestin-dependent extra MII was found for the peptides at residues 11–30 and 51–70 (IC50 < 100 μm) and residues 231–260 (IC50 < 200 μm). A similar pattern of inhibition by arrestin peptides was seen when arrestin was replaced by Gt or the farnesylated Gtγ C-terminal peptide. Only arrestin-(11–30) inhibited MII·Gt less (IC50 = 300 μm) than phosphorylated MII·arrestin. We interpreted the data by competition of the arrestin peptides for interaction sites at rhodopsin, exposed in the MII conformation and specific for both arrestin and Gt. The arrestin sites are located in both the C- and N-terminal domains of the arrestin structure. Arrestin blocks the interaction of rhodopsin with the G protein transducin (Gt). To characterize the sites of arrestin that interact with rhodopsin, we have utilized a spectrophotometric peptide competition assay. It is based on the stabilization of the active intermediates metarhodopsin II (MII) and phosphorylated MII by Gt and arrestin, respectively (extra MII monitor). The protocol involves native disc membranes and three sets of peptides 10–30 amino acids in length spanning the arrestin sequence. In the absence of arrestin, not one of the peptides by itself had an effect on the amount of MII formed. However, inhibition of arrestin-dependent extra MII was found for the peptides at residues 11–30 and 51–70 (IC50 < 100 μm) and residues 231–260 (IC50 < 200 μm). A similar pattern of inhibition by arrestin peptides was seen when arrestin was replaced by Gt or the farnesylated Gtγ C-terminal peptide. Only arrestin-(11–30) inhibited MII·Gt less (IC50 = 300 μm) than phosphorylated MII·arrestin. We interpreted the data by competition of the arrestin peptides for interaction sites at rhodopsin, exposed in the MII conformation and specific for both arrestin and Gt. The arrestin sites are located in both the C- and N-terminal domains of the arrestin structure. metarhodopsin II metarhodopsin I 1,3-bis[tris(hydroxymethyl)methylamino]propane G protein-coupled receptors enable eukaryotic cells to respond to a large variety of extracellular signals, including hormones, odorants, and light (1Baldwin J.M. Curr. Opin. Cell Biol. 1994; 6: 180-190Crossref PubMed Scopus (340) Google Scholar). One of the best studied G protein-coupled receptor-initiated signaling pathways is the visual cascade in retinal rods (2Hargrave P.A. McDowell J.H. FASEB J. 1992; 6: 2323-2331Crossref PubMed Scopus (233) Google Scholar). It is initiated by the absorption of a photon in the visual receptor (rhodopsin) and subsequent isomerization of the 11-cis-retinal, which is covalently attached to Lys296 in the seventh transmembrane helix of the receptor. Via a series of transient intermediates, rhodopsin converts in milliseconds into metarhodopsin II (MII),1 the form of rhodopsin that interacts with the heterotrimeric G protein transducin (Gt). This interaction initiates the intermolecular transduction of the light signal by catalyzing GDP/GTP exchange in the nucleotide-binding site of the G protein and in turn activates the G protein-coupled effector, a cGMP-specific phosphodiesterase. Hydrolysis of cGMP leads to the closure of plasma membrane cation channels and hyperpolarization of the membrane (3Helmreich E.J. Hofmann K.P. Biochim. Biophys. Acta. 1996; 1286: 285-322Crossref PubMed Scopus (127) Google Scholar). The deactivation of rhodopsin starts with the binding of a rhodopsin kinase to photoactivated rhodopsin (4Pulvermüller A. Palczewski K. Hofmann K.P. Biochemistry. 1993; 32: 14082-14088Crossref PubMed Scopus (87) Google Scholar). Rapid phosphorylation of the receptor at C-terminal sites (5Palczewski K. Eur. J. Biochem. 1997; 248: 261-269Crossref PubMed Scopus (100) Google Scholar) increases its affinity for arrestin (6Gibson S.K. Parkes J.H. Liebman P.A. Biochemistry. 2000; 39 (, and references therein): 5738-5749Crossref PubMed Scopus (65) Google Scholar). Biochemical (7Wilden U. Hall S.W. Kühn H. Proc. Natl. Acad. Sci. U. S. A. 1986; 83: 1174-1178Crossref PubMed Scopus (572) Google Scholar) and electrophysiological (8Xu J. Dodd R.L. Makino C.L. Simon M.I. Baylor D.A. Chen J. Nature. 1997; 389: 505-509Crossref PubMed Scopus (275) Google Scholar) evidence has been accumulated that visual arrestins deactivate the visual cascade by direct competition with the G protein for the active receptor. However, the mechanism of interaction underlying the quench is still not well understood. UV-visible spectroscopy has shown that, to bind arrestin, the light activation of rhodopsin must proceed up to the MII conformation, in which the Schiff base bond of the retinal to the apoprotein is still intact but deprotonated (9Schleicher A. Kühn H. Hofmann K.P. Biochemistry. 1989; 28: 1770-1775Crossref PubMed Scopus (166) Google Scholar). Only after MII formation and phosphorylation of the receptor, arrestin interacts rapidly with the receptor. Although the catalytic activity of MII for the G protein is quenched, arrestin binding (and phosphorylation) stabilizes MII at the expense of its tautomeric forms (6Gibson S.K. Parkes J.H. Liebman P.A. Biochemistry. 2000; 39 (, and references therein): 5738-5749Crossref PubMed Scopus (65) Google Scholar). A conformational difference in arrestin and/or rhodopsin on interaction was earlier suggested by the unusually high apparent activation energy of the rhodopsin-arrestin interaction (9Schleicher A. Kühn H. Hofmann K.P. Biochemistry. 1989; 28: 1770-1775Crossref PubMed Scopus (166) Google Scholar). Later studies have indeed shown that binding of arrestin to the active receptor protects arrestin against limited proteolysis (10Palczewski K. Pulvermüller A. Buczylko J. Hofmann K.P. J. Biol. Chem. 1991; 266: 18649-18654Abstract Full Text PDF PubMed Google Scholar) and lysine acetylation (11Ohguro H. Palczewski K. Walsh K.A. Johnson R.S. Protein Sci. 1994; 3: 2428-2434Crossref PubMed Scopus (83) Google Scholar), suggesting that rhodopsin-bound arrestin adopts a conformation (Ab) that is different from that of free inactive arrestin (Ai). Investigations employing protein engineering (12Gurevich V.V. Benovic J.L. J. Biol. Chem. 1993; 268: 11628-11638Abstract Full Text PDF PubMed Google Scholar, 13Gurevich V.V. Benovic J.L. Mol. Pharmacol. 1997; 51: 161-169Crossref PubMed Scopus (121) Google Scholar) and phosphorylated peptides (14Puig J. Arendt A. Tomson F.L. Abdulaeva G. Miller R. Hargrave P.A. McDowell J.H. FEBS Lett. 1995; 362: 185-188Crossref PubMed Scopus (70) Google Scholar) have provided evidence for a sequential mechanism, in which the contact of the negatively charged regions of phosphorylated rhodopsin with the cationic region acts as a trigger, switching arrestin into its active conformation and allowing interaction with the rhodopsin-binding sites exposed on photoactivation. A highly cationic region near the center of the arrestin sequence, beginning with residue 163, was proposed to mediate the interaction with the phosphorylated rhodopsin site, thus enabling the contact with other interaction sites exposed in the MII state (10Palczewski K. Pulvermüller A. Buczylko J. Hofmann K.P. J. Biol. Chem. 1991; 266: 18649-18654Abstract Full Text PDF PubMed Google Scholar). Arg175 (within the putative recognition site for the phosphorylated site(s) on rhodopsin) was identified as a key residue for arrestin to distinguish between phosphorylated and unphosphorylated rhodopsin (15Gurevich V.V. Benovic J.L. J. Biol. Chem. 1995; 270: 6010-6016Abstract Full Text Full Text PDF PubMed Scopus (142) Google Scholar, 16Gray Keller M.P. Detwiler P.B. Benovic J.L. Gurevich V.V. Biochemistry. 1997; 36: 7058-7063Crossref PubMed Scopus (80) Google Scholar). Recent structural assignments (17Granzin J. Wilden U. Choe H.-W. Labahn J. Krafft B. Buldt G. Nature. 1998; 391: 918-921Crossref PubMed Scopus (208) Google Scholar, 18Hirsch J.A. Schubert C. Gurevich V.V. Sigler P.B. Cell. 1999; 97: 257-269Abstract Full Text Full Text PDF PubMed Scopus (369) Google Scholar) have now identified this residue as part of a “polar core” (18Hirsch J.A. Schubert C. Gurevich V.V. Sigler P.B. Cell. 1999; 97: 257-269Abstract Full Text Full Text PDF PubMed Scopus (369) Google Scholar), a central region in arrestin localized between the N- and C-terminal domains of the molecule. It may act as a fulcrum for the conversion of inactive arrestin (Ai) to active bound arrestin (Ab) (19Vishnivetskiy S.A. Paz C.L. Schubert C. Hirsch J.A. Sigler P.B. Gurevich V.V. J. Biol. Chem. 1999; 274: 11451-11454Abstract Full Text Full Text PDF PubMed Scopus (158) Google Scholar). The conformational switch is additionally controlled by the arrestin C terminus (20Palczewski K. Buczylko J. Imami N.R. McDowell J.H. Hargrave P.A. J. Biol. Chem. 1991; 266: 15334-15339Abstract Full Text PDF PubMed Google Scholar, 21Gurevich V.V. Benovic J.L. J. Biol. Chem. 1992; 267: 21919-21923Abstract Full Text PDF PubMed Google Scholar). When it is lacking, as in a splice variant of arrestin (p44), the short arrestin binds both phosphorylated and unphosphorylated forms of MII and even C-terminally truncated rhodopsin (22Palczewski K. Buczylko J. Ohguro H. Annan R.S. Carr S.A. Crabb J.W. Kaplan M.W. Johnson R.S. Walsh K.A. Protein Sci. 1994; 3: 314-324Crossref PubMed Scopus (73) Google Scholar, 23Pulvermüller A. Maretzki D. Rudnicka Nawrot M. Smith W.C. Palczewski K. Hofmann K.P. Biochemistry. 1997; 36: 9253-9260Crossref PubMed Scopus (94) Google Scholar). Protein engineering (24Gurevich V.V. Chen C.Y. Kim C.M. Benovic J.L. J. Biol. Chem. 1994; 269: 8721-8727Abstract Full Text PDF PubMed Google Scholar) and spectroscopic data (25Wilson C.J. Copeland R.A. J. Protein Chem. 1997; 16: 755-763Crossref PubMed Scopus (23) Google Scholar) have suggested that in the inactive arrestin state(s), negatively charged C-terminal residues interact with positively charged residues on the N-terminal region and that this interaction is broken upon binding to phosphorylated MII. In this study, we have attempted to identify specific sites of arrestin that become exposed by the conformational switch, leading to their interaction with the respective receptor sites in the MII conformation. The technique applied is based on the spectrophotometric MII stabilization assay (9Schleicher A. Kühn H. Hofmann K.P. Biochemistry. 1989; 28: 1770-1775Crossref PubMed Scopus (166) Google Scholar) and on competition with peptides derived from arrestin and Gt. Peptide competition has already been applied in previous studies to map regions of interaction in the receptor-arrestin complex. Studies with peptides from the surface-exposed sequences of rhodopsin suggested a role of different loop structures in the interaction (26Krupnick J.G. Gurevich V.V. Schepers T. Hamm H.E. Benovic J.L. J. Biol. Chem. 1994; 269: 3226-3232Abstract Full Text PDF PubMed Google Scholar). Regarding the interactive domains in arrestin, Hargrave and co-workers (27Smith W.C. McDowell J.H. Dugger D.R. Miller R. Arendt A. Popp M.P. Hargrave P.A. Biochemistry. 1999; 38: 2752-2761Crossref PubMed Scopus (21) Google Scholar) have employed a library of peptides covering the entire sequence. Based on phage-display and phosphodiesterase activation data, they localized one of the principal regions of interaction within residues 109–130 and found indications of additional sites in their data (27Smith W.C. McDowell J.H. Dugger D.R. Miller R. Arendt A. Popp M.P. Hargrave P.A. Biochemistry. 1999; 38: 2752-2761Crossref PubMed Scopus (21) Google Scholar). We will indeed provide evidence that more than one region (namely three) in the arrestin molecule is involved in receptor binding. Employing the sensitive MII stabilization assay and peptide competition not only with arrestin, but also with Gt and Gt-derived peptides, we can measure with unprecedented specificity. Based on the data from three sets of overlapping synthetic 10–30-residue peptides spanning the arrestin sequence, we propose a model locating the receptor-binding regions of arrestin in each of the two domains of the molecule. Radioactive [γ-32P]ATP was purchased from PerkinElmer Life Sciences. All chemicals were purchased from Merck (Darmstadt, Germany), Roche Molecular Biochemicals, or Sigma. 11-cis-Retinal was generously provided by Dr. R. K. Crouch (Medical University of South Carolina). Rod outer segments were purified from fresh dark-adapted bovine retinas obtained from a local slaughterhouse using the discontinuous sucrose gradient method by PubMed Scopus Google Scholar). were and outer segments were All subsequent were at and the outer segments were at was by the and from the disc membrane by with a H. PubMed Scopus Google Scholar). All were and the membrane was at was from disc membranes as by Wilden and Kühn U. Kühn H. Biochemistry. PubMed Scopus Google Scholar). To from the phosphorylated the membranes were with and bovine K. Maretzki D. Hofmann K.P. 2000; PubMed Google Scholar). of was using [γ-32P]ATP as a rhodopsin was by of phosphorylated with K.P. Pulvermüller A. Buczylko J. Palczewski K. J. Biol. Chem. 1992; 267: Full Text PDF PubMed Google Scholar). was in 100 A of was in the to the by for at and at phosphorylated membranes were for with 100 to 11-cis-retinal, and at Arrestin was purified from dark-adapted bovine retinas as by M. Pulvermüller A. Hofmann K.P. 2000; PubMed Google Scholar). was from dark-adapted bovine retinas to and Hofmann M. Hofmann K.P. Biochemistry. 1993; 32: PubMed Scopus Google Scholar). were using the activation on an peptide The peptides were purified by high and at the the peptides were in to of and was to with of peptides was as Hofmann K.P. J. Biol. Chem. 2000; Full Text Full Text PDF PubMed Scopus Google Scholar). The of rhodopsin and phosphorylated rhodopsin were at as A. Maretzki D. Rudnicka Nawrot M. Smith W.C. Palczewski K. Hofmann K.P. Biochemistry. 1997; 36: 9253-9260Crossref PubMed Scopus (94) Google Scholar). arrestin was at a absorption of = K. J.H. Johnson W.C. Biochemistry. 1992; PubMed Scopus Google Scholar) and a of transducin was using the method Biochem. PubMed Scopus Google Scholar). of the metarhodopsin II = was using the technique (9Schleicher A. Kühn H. Hofmann K.P. Biochemistry. 1989; 28: 1770-1775Crossref PubMed Scopus (166) Google Scholar, C. H. Hofmann K.P. 2000; PubMed Google Scholar). This technique by the in the at and The at to as a for the of MII. The was with Germany), and a to When rhodopsin in its native disc membrane is to at which the is on the and J.H. S.K. Liebman P.A. Biochemistry. 1999; 38: PubMed Scopus Google Scholar), specific binding of protein or peptide to MII formation of MII (extra MII a and measure for the between photoactivated rhodopsin and the interactive K.P. Biochim. Biophys. Acta. PubMed Scopus Google Scholar). The by arrestin of the MII after a of light (extra is specific for rhodopsin and is not seen with unphosphorylated rhodopsin (9Schleicher A. Kühn H. Hofmann K.P. Biochemistry. 1989; 28: 1770-1775Crossref PubMed Scopus (166) Google Scholar, 23Pulvermüller A. Maretzki D. Rudnicka Nawrot M. Smith W.C. Palczewski K. Hofmann K.P. Biochemistry. 1997; 36: 9253-9260Crossref PubMed Scopus (94) Google Scholar). two of synthetic peptides derived from the arrestin the formation of extra MII from The arrestin peptide residues 11–30 the amount of extra MII in a and at arrestin-(11–30) extra MII to the arrestin This effect was not with even at extra MII was as with arrestin a of the peptides in this MII in the absence of arrestin in to transducin C-terminal peptides and farnesylated M. Hofmann K.P. Proc. Natl. Acad. Sci. U. S. A. 1999; PubMed Scopus Google Scholar). The inhibition of extra MII formation by arrestin peptides that they with their protein for rhodopsin-binding To this more overlapping sets of arrestin peptides with different were and their effect in the extra MII assay was of the peptides was up to a of the data for two arrestin peptides from 51–70 and and with the sequence, but not with a sequence, a effect on MII formation The to the data are with a direct effect of both peptides, with different sets of arrestin peptides covering the entire arrestin were and apparent are in may to a of the peptide to and not the between synthetic arrestin peptides and arrestin or transducin for binding to photoactivated inhibition by synthetic arrestin peptides of arrestin binding to phosphorylated metarhodopsin The extra MII assay was as in the to were with and inhibition of transducin binding to metarhodopsin II with the arrestin peptides as for A. the of extra MII (extra the as a of in the and absence of arrestin or Gt. the data for arrestin peptides with the sequences and and and the obtained from different sets of to the = a and are the and is the peptide is and is the The were as in the to arrestin-dependent formation of extra MII in the of synthetic arrestin disc membranes were with purified arrestin and of synthetic peptide. The the at the at the after the is to formation of MII effect of arrestin-(11–30) on extra MII effect of on extra MII with 100 with arrestin arrestin and peptide. In the in the were phosphorylated rhodopsin and for and were 100 at of 200 and length of rhodopsin was of arrestin binding to phosphorylated metarhodopsin II by synthetic arrestin and the were employing the extra MII assay were the as not in a and the were employing the extra MII assay were the as not forms MII with photoactivated unphosphorylated It is that arrestin the activity of photoactivated rhodopsin for the G protein (7Wilden U. Hall S.W. Kühn H. Proc. Natl. Acad. Sci. U. S. A. 1986; 83: 1174-1178Crossref PubMed Scopus (572) Google Scholar). We arrestin peptides can the formation of extra MII. shown in the two peptides that with arrestin also with Gt with similar a for direct interaction of the peptides with rhodopsin The was arrestin peptides with Gt-derived peptides in their interaction with photoactivated One may that this can by direct competition C-terminal peptides from Gt the MII state as the M. Hofmann K.P. Proc. Natl. Acad. Sci. U. S. A. 1999; PubMed Scopus Google Scholar, Hofmann K.P. FEBS Lett. 2000; PubMed Scopus Google Scholar), but arrestin peptides not two that arrestin peptides can indeed the formation of extra MII by Gt-derived The effect was seen with the farnesylated Gtγ an of the respective binding sites at inhibition was for the interaction with the C-terminal peptide and high affinity shown in the peptides that with arrestin with Gt and the Gtγ C-terminal peptide as is the region near the which competition with Gt and the farnesylated Gtγ peptide with arrestin The data provide on the receptor-binding sites of the arrestin for of visual transduction in overlapping sets of synthetic peptides and their competition with the protein for the phosphorylated receptor, we identified peptides from three regions of the arrestin that with The respective of the are located in both the N- and C-terminal domains of the protein structure. The regions of peptide competition for interaction sites with active phosphorylated However, it is that peptide competition by itself is not the peptides sites of involved in to the active conformation. we that a conformational switch in arrestin this is A was found in the of arrestin with Gt and The data in that of the peptides that with arrestin also with Gt and the farnesylated Gtγ C-terminal peptide. The of competition between and was also in arrestin and Gt are to this can as evidence for binding of arrestin and Gt or its farnesylated Gtγ peptide to the rhodopsin with is similar to the one by Smith (27Smith W.C. McDowell J.H. Dugger D.R. Miller R. Arendt A. Popp M.P. Hargrave P.A. Biochemistry. 1999; 38: 2752-2761Crossref PubMed Scopus (21) Google Scholar), employed overlapping synthetic peptides to regions of arrestin that bind to a phage-display technique of arrestin and Gt binding and activation identified a residues 109–130 as a site involved in the interaction with of the affinity of this region (IC50 = it was suggested that this of arrestin may only one of binding sites for rhodopsin (27Smith W.C. McDowell J.H. Dugger D.R. Miller R. Arendt A. Popp M.P. Hargrave P.A. Biochemistry. 1999; 38: 2752-2761Crossref PubMed Scopus (21) Google Scholar). In the study, using the different extra MII we indeed found peptide competition with similar in this region but competition in other residues 11–30 and 51–70 (IC50 < 100 μm) and residues (IC50 < 200 μm). regions and with are located in the arrestin C- and N-terminal domains I and The for of sites by assay is the of the as they within after the light The region near the terminus but is only in the visual or C.M. FEBS Lett. 1995; 362: PubMed Scopus (65) Google Scholar). This is also the region the only difference between arrestin and Gt competition a role both in rhodopsin-arrestin interaction and in the switch mechanism in with the from studies (19Vishnivetskiy S.A. Paz C.L. Schubert C. Hirsch J.A. Sigler P.B. Gurevich V.V. J. Biol. Chem. 1999; 274: 11451-11454Abstract Full Text Full Text PDF PubMed Scopus (158) Google Scholar). In the of in this region for a specific role in visual and arrestins with the G a conformational switch, by the contact with the active receptor (3Helmreich E.J. Hofmann K.P. Biochim. Biophys. Acta. 1996; 1286: 285-322Crossref PubMed Scopus (127) Google Scholar, A. Kühn H. Hofmann K.P. Biochemistry. 1989; 28: 1770-1775Crossref PubMed Scopus (166) Google Scholar, K. Pulvermüller A. Buczylko J. Hofmann K.P. J. Biol. Chem. 1991; 266: 18649-18654Abstract Full Text PDF PubMed Google Scholar, V.V. Benovic J.L. J. Biol. Chem. 1993; 268: 11628-11638Abstract Full Text PDF PubMed Google Scholar, 13Gurevich V.V. Benovic J.L. Mol. Pharmacol. 1997; 51: 161-169Crossref PubMed Scopus (121) Google Scholar). Based on structural Sigler and co-workers (18Hirsch J.A. Schubert C. Gurevich V.V. Sigler P.B. Cell. 1999; 97: 257-269Abstract Full Text Full Text PDF PubMed Scopus (369) Google Scholar, S.A. Paz C.L. Schubert C. Hirsch J.A. Sigler P.B. Gurevich V.V. J. Biol. Chem. 1999; 274: 11451-11454Abstract Full Text Full Text PDF PubMed Scopus (158) Google Scholar) have a mechanism of the conformational switch, in which the phosphorylated C terminus of the receptor interacts with the between the N- and C-terminal domains in the fulcrum of the molecule. this including a of and between charged are leading to structural an of the N- and C-terminal domains (18Hirsch J.A. Schubert C. Gurevich V.V. Sigler P.B. Cell. 1999; 97: 257-269Abstract Full Text Full Text PDF PubMed Scopus (369) Google Scholar). Although the two structures of arrestin are not in with each other in as the of the and C one may to the identified binding sites to the structural The structures shown in (17Granzin J. Wilden U. Choe H.-W. Labahn J. Krafft B. Buldt G. Nature. 1998; 391: 918-921Crossref PubMed Scopus (208) Google Scholar, 18Hirsch J.A. Schubert C. Gurevich V.V. Sigler P.B. Cell. 1999; 97: 257-269Abstract Full Text Full Text PDF PubMed Scopus (369) Google Scholar) are both to the inactive conformation of the molecule. The sites identified in the are and not form a A conformational switch may thus to their interaction with the receptor loop The is similar for the G protein two sites C of the and which are are involved in the signal M. Hofmann K.P. Proc. Natl. Acad. Sci. U. S. A. 1999; PubMed Scopus Google Scholar). arrestin and Gt 23Pulvermüller A. Maretzki D. Rudnicka Nawrot M. Smith W.C. Palczewski K. Hofmann K.P. Biochemistry. 1997; 36: 9253-9260Crossref PubMed Scopus (94) Google and J.H. S.K. Liebman P.A. Biochemistry. 1999; 38: PubMed Scopus Google Scholar, the binding of two receptors at one molecule is the of the the in conformational arrestin and Gt to different of site to the G it is that the and farnesylated Gtγ C-terminal sequences have the to the MII and to distinguish it from the other intermediates M. Hofmann K.P. Proc. Natl. Acad. Sci. U. S. A. 1999; PubMed Scopus Google Scholar, H.E. D. Arendt A. Hargrave P.A. B. Hofmann K.P. PubMed Scopus Google Scholar). of the arrestin peptides for the stabilization of MII and for Although we of this when competition with the Gt peptides, we not its All we can is that the arrestin protein the to the MII conformation with high We have identified of the sites involved in the interaction between arrestin and its receptor. However, it that this interaction may in in that to the of K. Chen J. Biochemistry. 1999; 38: PubMed Scopus Google Scholar). It to studied the of arrestin is and it on the interaction sites identified We Dr. for the synthetic arrestin peptides, Dr. for Dr. for the and and for The was to A is arrestin, is rhodopsin, and different arrestin The for three and three and the of arrestin, and arrestin peptides, The was to J.H. S.K. Liebman P.A. Biochemistry. 1999; 38: PubMed Scopus Google was using the from the rhodopsin-arrestin A. Maretzki D. Rudnicka Nawrot M. Smith W.C. Palczewski K. Hofmann K.P. Biochemistry. 1997; 36: 9253-9260Crossref PubMed Scopus (94) Google Scholar). and are the of rhodopsin, arrestin, and arrestin peptides, of can as The the arrestin peptide at which the extra MII signal is inhibited to that peptide binding to rhodopsin or rhodopsin to similar <
43
Crystal Structure of Rhodopsin: A G Protein-Coupled Receptor
Krzysztof Palczewski, Takashi Kumasaka, Tetsuya Hori et al. · Science · 2000 · 5.6K citations
Ursula Wilden, S W Hall, H. Kühn · Proceedings of the National Academy of Sciences · 1986 · 793 citations · Full text
Site of G Protein Binding to Rhodopsin Mapped with Synthetic Peptides from the α Subunit
Heidi E. Hamm, Dusanka Deretic, Anatol Arendt et al. · Science · 1988 · 498 citations